73579000: Carbidopa (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Antiparkinsonian agent (substance)\...

\Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (substance)\Carbidopa

\Dihydroxyphenylalanine\Carbidopa

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Carbidopa

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Carbidopa

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

122178011 Carbidopa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

122179015 MK-486 en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

813982014 Carbidopa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3736797013 Alpha-methyldopa hydrazine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

51091000195114 carbidopa it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

797681000172110 carbidopa fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

66221000195116 Carbidopa de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Carbidopa	Is a	Co-careldopa	false	Inferred relationship	Some
Carbidopa	Is a	Antiparkinsonian agent (substance)	false	Inferred relationship	Some
Carbidopa	Is a	Co-careldopa	false	Inferred relationship	Some
Carbidopa	Is a	Dihydroxyphenylalanine	true	Inferred relationship	Some
Carbidopa	Is a	Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (substance)	true	Inferred relationship	Some
Carbidopa	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Dopamine receptor agonist (disposition)	true	Inferred relationship	Some
Carbidopa	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Dihydroxyphenylalanine decarboxylase inhibitor (disposition)	true	Inferred relationship	Some
Carbidopa	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carbidopa	Inferred relationship	Some	3
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Carbidopa	Inferred relationship	Some	3
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Carbidopa	Inferred relationship	Some	3
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carbidopa	Inferred relationship	Some	3
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Carbidopa	Inferred relationship	Some	3
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carbidopa	Inferred relationship	Some	3
Product containing precisely carbidopa anhydrous (as carbidopa) 43.75 milligram and entacapone 200 milligram and levodopa 175 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Carbidopa	Inferred relationship	Some	3
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Carbidopa	Inferred relationship	Some	3

Start Page 2 of 2

This concept is not in any reference sets